Nortem Biogroup (XPAR:MLBIO) 3-Year Revenue Growth Rate : 0.00% (As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup 3-Year Revenue Growth Rate?

Nortem Biogroup's Revenue per Share for the six months ended in Dec. 2022 was €2.71.

During the past 12 months, Nortem Biogroup's average Revenue per Share Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Competitive Comparison of Nortem Biogroup's 3-Year Revenue Growth Rate

For the Packaged Foods subindustry, Nortem Biogroup's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's 3-Year Revenue Growth Rate Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's 3-Year Revenue Growth Rate falls into.

Nortem Biogroup 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Nortem Biogroup (XPAR:MLBIO) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Nortem Biogroup 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines